On December 30, 2019 Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, reported it will present at leading healthcare conferences in San Francisco, California at the beginning of January 2020 (Press release, Gracell Biotechnologies, DEC 30, 2019, View Source [SID1234552636]). Gracell will present at the 38th Annual J.P. Morgan Healthcare Conference, held between January 13-16, 2020 at The Westin St. Francis Hotel on Union Square.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Focused exclusively on companies defining the healthcare industry, the J.P. Morgan Healthcare Conference is the largest of its kind and will welcome over 400 public and private companies to deliver presentations to over 8,000 attendees, including investors and industry leaders.

"We are delighted to be invited to present at some of the most recognized and regarded events in the healthcare industry," said Dr. William Cao, CEO of Gracell. "The invaluable data from Gracell’s clinical trials demonstrates our strong capabilities to bring multiple novel technologies to the forefront of immune cell therapy field. We are eager to share these findings with the global healthcare community."

Gracell will also present at the following conference in January.

China Showcase
Presentation time: 4:00pm, Sunday, January 12
Location: Parc 55 San Francisco – A Hilton Hotel
Track: Cyrill Magnin III (4th floor)

Biotech Showcase
Presentation time: 10:00am, Monday, January 13
Location: Hilton San Francisco Union Square Hotel
Track: Franciscan B (Ballroom Level)